Results 301 to 310 of about 67,076 (344)
Some of the next articles are maybe not open access.

Dietary management of Type I glycogen storage disease

Journal of the American Dietetic Association, 1984
The most commonly recognized type of glycogen storage disease (von Gierke's disease) results from deficient glucose-6-phosphatase activity. This enzyme is the last step in the release of free glucose from the liver into the circulation. Thus, the most prominent and life-threatening complication in the illness is severe and often prolonged hypoglycemia,
Harry L. Greene, Cathy C. Folk
openaire   +3 more sources

Glycogen storage disease type I in Tunisia: An epidemiological analysis

Journal of Inherited Metabolic Disease, 2008
SummaryObjective: Analysis of epidemiological data concerning GSD I in Tunisia. Subjects and methods: All the cases diagnosed as GSD I between 1992 and 2005 in a paediatric department recruiting all the metabolic diseases referred from the North of Tunisia were reviewed. Individual data (sex, socioeconomic and educational background, geographic origins,
H. Ben Turkia   +6 more
openaire   +3 more sources

Ischemic stroke in an adult with glycogen storage disease type I

Journal of Clinical Neuroscience, 2010
Glycogen Storage Disease Type I (GSD-I) is a metabolic disorder characterized by deficiency of glucose-6-phosphatase resulting in ineffective glycogen metabolism to glucose. These patients frequently have hyperlipidemia, among many other metabolic derangements. There is no consensus regarding the risk of developing atherosclerosis.
Stanley Tuhrim   +4 more
openaire   +3 more sources

Dental management of a patient with glycogen storage disease type I

The Journal of the American Dental Association, 1985
Patients with glycogen storage disease type I (GSD I) have varied medical problems, including a bleeding diathesis characterized by a prolonged bleeding time. A case of a patient with GSD I having a history of medical problems, some of which were related to oral and dental bleeding, was presented. The patient was cariesfree and had generalized moderate
Edward C. Marshall   +2 more
openaire   +3 more sources

Endogenous glucose production in type I glycogen storage disease

Metabolism, 1981
The adaptive mechanisms that protect some patients with Type I glycogen storage disease from fasting hypoglycemia were examined in two young adults. Both maintained low normal fasting plasma glucose concentrations even during 3 day fasts; blood lactate concentrations increased during the first 12 hr and then decreased to normal during the second and ...
Samuel M. Wentworth   +2 more
openaire   +3 more sources

The use of alanine, free carnitine and IGFBP-1 as potential biomarkers for glycogen storage disease type I

Molecular Genetics and Metabolism, 2022
H. Saavedra   +2 more
semanticscholar   +1 more source

[Advances on the management of renal lesion in glycogen storage disease type I].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2021
W. Wu, J. S. Wang
semanticscholar   +1 more source

Glycogen storage disease type I patients with hyperlipidemia have no signs of early vascular dysfunction and premature atherosclerosis.

NMCD. Nutrition Metabolism and Cardiovascular Diseases, 2021
J. Schmitt   +5 more
semanticscholar   +1 more source

Onconephrology: The intersections between the kidney and cancer

Ca-A Cancer Journal for Clinicians, 2021
Mitchell H Rosner   +2 more
exaly  

Home - About - Disclaimer - Privacy